Kathy is a China-registered Patent Attorney. Her expertise is in the biological field, such as pharmaceuticals, antibodies, cell therapy, gene therapy, transgenic plants, nucleic acids, proteins and the like. Kathy provides advice about patent filing and prosecution for various clients including universities, research institutes, and companies. She also has experience in IP due diligence, FTO analysis, patent invalidation and patent infringement litigation in China.
Kathy graduated with a BSc degree in Applied Biology from Zhejiang University (China) in 2008 and a PhD degree from the Department of Biological Science at National University of Singapore in 2013. After completing her doctoral studies, she worked in a leading Japanese law firm (Osaka, Japan) for 2 years, and subsequently in a tier-1 international law firm based in Shanghai (China) for another 5 years. Before moving to Singapore and joining Marks & Clerk, she worked in a biotech start-up in Nanjing (China) focusing on cell therapy as an IP Director.
PhD